Sinclair Pharma Share News (SPH)

Sinclair Pharma's revenues grew 47% on a constant currency basis and this has provided a boost for the shares and taken them above the 28p a share placing price earlier this year. Like-for-like revenues, excluding acquisitions and disposals, grew 9%. Flammazine, a cream to prevent infections in burns acquired at the beginning of 2010, generated revenues 26% ahead of budget. France, which generates one-third of revenues, is growing again. The £19m raised during the summer gives Sinclair a strong balance sheet. Germ killing products supplier Puricore shares have fallen back after its third quarter trading statement. Third quarter sales were 5% higher than one year ago at $11.1m, with strong growth in endoscopy revenues but the Labcaire business was acquired last August so it did not contribute a full three months figures to the third quarter of 2009. There was a decline in the food safety business. Retailers are deciding on their budgets for 2011 and this will determine demand for next year. Gross margins rose from 26.1% to more than 32%.Revenues are 2% ahead at $30.2m in the first nine months of 2010. Puricore has launched a bottled version of its wound care treatment. FTSE TechMARK - RisersAsterand (ATD) 11.75p +11.90%Sinclair Pharma (SPH) 29.00p +6.42%Renovo Group (RNVO) 39.00p +4.70%Ceva Inc. (CVA) 1,250.00p +4.17%Vectura Group (VEC) 66.00p +3.12%E2V Technologies (E2V) 95.00p +1.60%Corin Group (CRG) 49.00p +1.55%Smith & Nephew (SN.) 595.00p +1.28%Alterian (ALN) 190.25p +1.20%Dialight (DIA) 429.75p +1.12%FTSE TechMARK - FallersTorotrak (TRK) 20.00p -5.88%Kewill (KWL) 97.00p -4.43%Cable & Wireless Worldwide (CW.) 67.30p -3.24%Pace (PIC) 195.50p -3.17%Xaar (XAR) 224.00p -3.03%Puricore (PURI) 59.00p -2.48%Oxford Instruments (OXIG) 524.00p -2.42%Anite (AIE) 52.75p -2.31%AEA Technology Group (AAT) 5.75p -2.21%XP Power Ltd. (DI) (XPP) 980.00p -2.20%